Research Article
Maternal Plasma miRNAs Expression in Preeclamptic Pregnancies
Table 2
Characteristics of study subjects.
| Characteristics | SOLiD sequencing | RT-PCR validation | Mild preeclampsia () | Severe preeclampsia () | Normal control () | Mild preeclampsia () | Severe preeclampsia () | Normal control () |
| Maternal age (years) | 29 (23–36) | 34 (28–39) | 28 (26–30) | 31 (26–39) | 33 (24–43) | 29 (25–36) | Gestational age (weeks) | 35.5 (34–37) | 35 (32–38) | 37 (36–38) | 36.2 (32–38) | 34.7 (28–37) | 36.8 (34–38) | Gravidity | 2 (1–3) | 1.5 (1-2) | 1.25 (1-2) | 1.8 (1–4) | 2.1 (1–3) | 1.6 (1–3) | Prepregnancy weight (kg) | 60 (50–68) | 65 (60–70) | 59 (55–62) | 64 (48–72) | 67 (52–77) | 62 (55–74) | Birth weight (kg) | 2.97 (2.6–3.2) | 2.81 (2.4–3.4) | 3.35 (3.1–3.6) | 2.86 (2.4–3.4) | 2.71 (2.1–3.6) | 3.62 (2.6–4.1) | Systolic blood pressure (mmHg) | 143 (140–148) | 170 (165–180) | 100 (90–110) | 144 (140–152) | 172 (160–200) | 108 (90–120) | Diastolic blood pressure (mmHg) | 92.5 (90–95) | 115 (110–120) | 70 (60–80) | 96 (90–105) | 114 (110–120) | 76 (60–88) |
|
|
Values expressed as median (range).
|